Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer
Open Access
- 26 April 2011
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 104 (10), 1558-1563
- https://doi.org/10.1038/bjc.2011.140
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009Annals Of Oncology, 2009
- Elevated Breast Cancer Mortality in Women Younger than Age 40 Years Compared with Older Women Is Attributed to Poorer Survival in Early-Stage DiseaseJournal of the American College of Surgeons, 2009
- Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancerAnnals of Oncology, 2009
- Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancerBritish Journal of Cancer, 2008
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trialThe Lancet Oncology, 2008
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- Early discontinuation of tamoxifenCancer, 2007
- Adherence to tamoxifen over the five-year courseBreast Cancer Research and Treatment, 2006
- Adherence to MedicationThe New England Journal of Medicine, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005